ARCH Venture Partners IX Overage, L.P. — SEC insider filings

SEC reporting owner CIK 1723172. 29 insider filings on record with FilingPulse; latest filed 2026-11-05.

Transaction summary — filings shown

Covers all 29 filings on record, filed 2020-11-16 to 2026-11-05. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Lyell Immunopharma, Inc. (LYEL)10% owner42 legs · 2,809,352 sh · $37,499,977—6
Sana Biotechnology, Inc. (SANA)10% owner23 legs · 1,818,181 sh · $9,999,996—14
Boundless Bio, Inc. (BOLD)10% owner22 legs · 200,000 sh · $3,200,0001 leg · 16,000 sh · $39,84012
Vir Biotechnology, Inc. (VIR)10% owner14——95
Beam Therapeutics Inc. (BEAM)10% owner4——27
Karuna Therapeutics, Inc. (KRTX)10% owner3——12

Insider filings — ARCH Venture Partners IX Overage, L.P.

FiledFormIssuerReported transactionsSource
2026-11-054Lyell Immunopharma, Inc. (LYEL)
jointly with ARCH Venture Partners IX, LLC, ARCH Venture Fund IX, L.P., ARCH Venture Partners IX, L.P., ARCH Venture Fund IX Overage, L.P.
Purchase (P): 2,321,262 @ $10.77EDGAR
2026-07-064Boundless Bio, Inc. (BOLD)
jointly with ARCH Venture Fund IX, L.P., ARCH Venture Fund IX Overage, L.P., ARCH Venture Fund X Overage, L.P., ARCH Venture Partners IX, L.P., ARCH Venture Partners X Overage, L.P., ARCH Venture Partners IX, LLC, ARCH Venture Partners X, LLC
Option exercise (M): 16,000 @ $1.03 · Sale (S): 16,000 @ $2.49 · Option exercise (M): 16,000 (derivative) @ $0EDGAR
2026-03-094Lyell Immunopharma, Inc. (LYEL)
jointly with ARCH Venture Partners IX, LLC, ARCH Venture Partners IX, L.P., ARCH Venture Fund IX, L.P., ARCH Venture Fund IX Overage, L.P.
Purchase (P): 488,090 @ $25.61EDGAR
2025-07-294Lyell Immunopharma, Inc. (LYEL)
jointly with ARCH Venture Partners IX, LLC, ARCH Venture Partners IX, L.P., ARCH Venture Fund IX, L.P., ARCH Venture Fund IX Overage, L.P., CRANDELL KEITH, BYBEE CLINTON, NELSEN ROBERT
Holdings only — no transactions reportedEDGAR
2024-04-044Boundless Bio, Inc. (BOLD)
jointly with ARCH Venture Fund IX, L.P., ARCH Venture Fund IX Overage, L.P., ARCH Venture Fund X Overage, L.P., ARCH Venture Partners IX, L.P., ARCH Venture Partners X Overage, L.P., ARCH Venture Partners IX, LLC, ARCH Venture Partners X, LLC
Conversion (C): 589,743 · Conversion (C): 787,545 · Conversion (C): 1,048,433 · Purchase (P): 66,667 @ $16 · Purchase (P): 133,333 @ $16 · Conversion (C): 424,908 (derivative) · +6 moreEDGAR
2024-02-124Sana Biotechnology, Inc. (SANA)
jointly with ARCH Venture Fund X, L.P., ARCH Venture Fund X Overage, L.P., ARCH Venture Fund IX, L.P., ARCH Venture Fund IX Overage, L.P., ARCH Venture Partners IX, L.P., ARCH Venture Partners X, L.P., ARCH Venture Partners X Overage, L.P., ARCH Venture Partners IX, LLC, ARCH Venture Partners X, LLC
Purchase (P): 363,637 @ $5.50 · Purchase (P): 727,272 @ $5.50 · Purchase (P): 727,272 @ $5.50EDGAR
2022-09-074Vir Biotechnology, Inc. (VIR)
jointly with ARCH Venture Partners IX, LLC, ARCH Venture Partners IX, L.P., ARCH Venture Fund IX, L.P., ARCH Venture Fund IX Overage, L.P., CRANDELL KEITH, BYBEE CLINTON
Other (J): 196,003 @ $0 · Other (J): 253,997 @ $0 · Other (J): 11,763 @ $0 · Other (J): 1,338 @ $0 · Other (J): 2,662 @ $0 · Other (J): 239,559 @ $0 · +4 moreEDGAR
2022-09-014Vir Biotechnology, Inc. (VIR)
jointly with ARCH Venture Partners IX, LLC, ARCH Venture Partners IX, L.P., ARCH Venture Fund IX, L.P., ARCH Venture Fund IX Overage, L.P., CRANDELL KEITH, BYBEE CLINTON
Other (J): 217,781 @ $0 · Other (J): 282,219 @ $0 · Other (J): 13,076 @ $0 · Other (J): 1,475 @ $0 · Other (J): 2,952 @ $0 · Other (J): 217,781 @ $0 · +4 moreEDGAR
2022-08-264Vir Biotechnology, Inc. (VIR)
jointly with ARCH Venture Partners IX, LLC, ARCH Venture Partners IX, L.P., ARCH Venture Fund IX, L.P., ARCH Venture Fund IX Overage, L.P., CRANDELL KEITH, BYBEE CLINTON
Other (J): 217,781 @ $0 · Other (J): 282,219 @ $0 · Other (J): 13,076 @ $0 · Other (J): 1,475 @ $0 · Other (J): 2,952 @ $0 · Other (J): 217,781 @ $0 · +4 moreEDGAR
2022-08-224Vir Biotechnology, Inc. (VIR)
jointly with ARCH Venture Partners IX, LLC, ARCH Venture Partners IX, L.P., ARCH Venture Fund IX, L.P., ARCH Venture Fund IX Overage, L.P., CRANDELL KEITH, BYBEE CLINTON
Other (J): 217,781 @ $0 · Other (J): 282,219 @ $0 · Other (J): 13,076 @ $0 · Other (J): 1,475 @ $0 · Other (J): 2,952 @ $0EDGAR
2022-08-164Vir Biotechnology, Inc. (VIR)
jointly with ARCH Venture Partners IX, LLC, ARCH Venture Partners IX, L.P., ARCH Venture Fund IX, L.P., ARCH Venture Fund IX Overage, L.P., CRANDELL KEITH, BYBEE CLINTON
Other (J): 217,781 @ $0 · Other (J): 282,219 @ $0 · Other (J): 13,076 @ $0 · Other (J): 1,475 @ $0 · Other (J): 2,952 @ $0 · Other (J): 217,781 @ $0 · +9 moreEDGAR
2022-06-104Vir Biotechnology, Inc. (VIR)
jointly with ARCH Venture Partners IX, LLC, ARCH Venture Partners IX, L.P., ARCH Venture Fund IX, L.P., ARCH Venture Fund IX Overage, L.P., CRANDELL KEITH, BYBEE CLINTON
Other (J): 217,781 @ $0 · Other (J): 282,219 @ $0 · Other (J): 13,076 @ $0 · Other (J): 1,475 @ $0 · Other (J): 2,952 @ $0EDGAR
2022-06-064Vir Biotechnology, Inc. (VIR)
jointly with ARCH Venture Partners IX, LLC, ARCH Venture Partners IX, L.P., ARCH Venture Fund IX, L.P., ARCH Venture Fund IX Overage, L.P., CRANDELL KEITH, BYBEE CLINTON
Other (J): 217,781 @ $0 · Other (J): 282,219 @ $0 · Other (J): 13,076 @ $0 · Other (J): 4,426 @ $0EDGAR
2021-12-224Vir Biotechnology, Inc. (VIR)
jointly with ARCH Venture Partners IX, LLC, ARCH Venture Partners IX, L.P., ARCH Venture Fund IX, L.P., ARCH Venture Fund IX Overage, L.P., CRANDELL KEITH, BYBEE CLINTON
Other (J): 762,233 @ $0 · Other (J): 987,767 @ $0 · Other (J): 45,703 @ $0 · Other (J): 15,504 @ $0EDGAR
2021-12-014Vir Biotechnology, Inc. (VIR)
jointly with ARCH Venture Partners IX, LLC, ARCH Venture Partners IX, L.P., ARCH Venture Fund IX, L.P., ARCH Venture Fund IX Overage, L.P., CRANDELL KEITH, BYBEE CLINTON
Other (J): 217,781 @ $0 · Other (J): 282,219 @ $0 · Other (J): 13,057 @ $0 · Other (J): 4,428 @ $0EDGAR
2021-11-244Vir Biotechnology, Inc. (VIR)
jointly with ARCH Venture Partners IX, LLC, ARCH Venture Partners IX, L.P., ARCH Venture Fund IX, L.P., ARCH Venture Fund IX Overage, L.P., CRANDELL KEITH, BYBEE CLINTON
Other (J): 217,781 @ $0 · Other (J): 282,219 @ $0 · Other (J): 13,057 @ $0 · Other (J): 4,428 @ $0EDGAR
2021-07-064Vir Biotechnology, Inc. (VIR)
jointly with ARCH Venture Partners IX, LLC, ARCH Venture Partners IX, L.P., ARCH Venture Fund IX, L.P., ARCH Venture Fund IX Overage, L.P., CRANDELL KEITH, BYBEE CLINTON
Other (J): 1,742,248 @ $0 · Other (J): 2,257,752 @ $0 · Other (J): 25,279 @ $0 · Other (J): 8,133 @ $0EDGAR
2021-07-024Beam Therapeutics Inc. (BEAM)
jointly with ARCH Venture Partners IX, LLC, ARCH Venture Partners IX, L.P., ARCH Venture Fund IX, L.P., ARCH Venture Fund IX Overage, L.P., CRANDELL KEITH, BYBEE CLINTON, NELSEN ROBERT
Other (J): 200,000 @ $0 · Other (J): 200,000 @ $0 · Other (J): 2,555 @ $0 · Other (J): 811 @ $0 · Other (J): 4,686 @ $0EDGAR
2021-06-294Beam Therapeutics Inc. (BEAM)
jointly with ARCH Venture Partners IX, LLC, ARCH Venture Partners IX, L.P., ARCH Venture Fund IX, L.P., ARCH Venture Fund IX Overage, L.P., CRANDELL KEITH, BYBEE CLINTON, NELSEN ROBERT
Other (J): 200,000 @ $0 · Other (J): 200,000 @ $0 · Other (J): 2,555 @ $0 · Other (J): 811 @ $0 · Other (J): 4,686 @ $0 · Other (J): 200,000 @ $0 · +4 moreEDGAR
2021-06-244Vir Biotechnology, Inc. (VIR)
jointly with ARCH Venture Partners IX, LLC, ARCH Venture Partners IX, L.P., ARCH Venture Fund IX, L.P., ARCH Venture Fund IX Overage, L.P., CRANDELL KEITH, BYBEE CLINTON
Other (J): 435,562 @ $0 · Other (J): 564,438 @ $0 · Other (J): 6,320 @ $0 · Other (J): 2,028 @ $0EDGAR
2021-06-234Lyell Immunopharma, Inc. (LYEL)
jointly with ARCH Venture Partners IX, LLC, ARCH Venture Fund IX Overage, L.P., ARCH Venture Fund IX, L.P., ARCH Venture Partners IX, L.P., CRANDELL KEITH, BYBEE CLINTON
Conversion (C): 18,206,358 · Conversion (C): 18,206,358 · Conversion (C): 17,771,216 (derivative) @ $0 · Conversion (C): 17,771,216 (derivative) @ $0 · Conversion (C): 435,142 (derivative) @ $0 · Conversion (C): 435,142 (derivative) @ $0EDGAR
2021-04-154Karuna Therapeutics, Inc. (KRTX)
jointly with ARCH Venture Partners IX, LLC, ARCH Venture Partners IX, L.P., ARCH Venture Fund IX, L.P., ARCH Venture Fund IX Overage, L.P., BYBEE CLINTON, CRANDELL KEITH
Other (J): 75,000 @ $0 · Other (J): 75,000 @ $0 · Other (J): 958 @ $0 · Other (J): 306 @ $0EDGAR
2021-04-094Vir Biotechnology, Inc. (VIR)
jointly with ARCH Venture Partners IX, LLC, ARCH Venture Partners IX, L.P., ARCH Venture Fund IX, L.P., ARCH Venture Fund IX Overage, L.P., CRANDELL KEITH, BYBEE CLINTON
Other (J): 217,781 @ $0 · Other (J): 282,219 @ $0 · Other (J): 3,161 @ $0 · Other (J): 1,019 @ $0 · Other (J): 217,781 @ $0 · Other (J): 282,219 @ $0 · +2 moreEDGAR
2021-04-024Beam Therapeutics Inc. (BEAM)
jointly with ARCH Venture Partners IX, LLC, ARCH Venture Partners IX, L.P., ARCH Venture Fund IX, L.P., ARCH Venture Fund IX Overage, L.P., CRANDELL KEITH, BYBEE CLINTON
Other (J): 200,000 @ $0 · Other (J): 200,000 @ $0 · Other (J): 2,555 @ $0 · Other (J): 811 @ $0EDGAR
2021-04-014Vir Biotechnology, Inc. (VIR)
jointly with ARCH Venture Partners IX, LLC, ARCH Venture Partners IX, L.P., ARCH Venture Fund IX, L.P., ARCH Venture Fund IX Overage, L.P., CRANDELL KEITH, BYBEE CLINTON
Other (J): 217,781 @ $0 · Other (J): 282,219 @ $0 · Other (J): 3,160 @ $0 · Other (J): 1,014 @ $0 · Other (J): 217,781 @ $0 · Other (J): 282,219 @ $0 · +2 moreEDGAR
2021-03-224Beam Therapeutics Inc. (BEAM)
jointly with ARCH Venture Partners IX, LLC, ARCH Venture Partners IX, L.P., ARCH Venture Fund IX, L.P., ARCH Venture Fund IX Overage, L.P., CRANDELL KEITH, BYBEE CLINTON
Other (J): 200,000 @ $0 · Other (J): 200,000 @ $0 · Other (J): 2,553 @ $0 · Other (J): 810 @ $0 · Other (J): 200,000 @ $0 · Other (J): 200,000 @ $0 · +2 moreEDGAR
2021-02-104Sana Biotechnology, Inc. (SANA)
jointly with ARCH Venture Fund X, L.P., ARCH Venture Fund IX, L.P., ARCH Venture Fund IX Overage, L.P., ARCH Venture Fund X Overage, L.P., ARCH Venture Partners IX, L.P., ARCH Venture Partners X, L.P., ARCH Venture Partners X Overage, L.P., ARCH Venture Partners IX, LLC, ARCH Venture Partners X, LLC
Conversion (C): 10,156,250 · Conversion (C): 10,156,250 · Conversion (C): 11,718,750 · Conversion (C): 11,718,750 · Conversion (C): 3,687,500 (derivative) @ $0 · Conversion (C): 3,687,500 (derivative) @ $0 · +8 moreEDGAR
2021-01-124Karuna Therapeutics, Inc. (KRTX)
jointly with ARCH Venture Partners IX, LLC, ARCH Venture Partners IX, L.P., ARCH Venture Fund IX, L.P., ARCH Venture Fund IX Overage, L.P., BYBEE CLINTON, CRANDELL KEITH
Other (J): 75,000 @ $0 · Other (J): 75,000 @ $0 · Other (J): 958 @ $0 · Other (J): 306 @ $0EDGAR
2020-11-164Karuna Therapeutics, Inc. (KRTX)
jointly with ARCH Venture Partners IX, LLC, ARCH Venture Partners IX, L.P., ARCH Venture Fund IX, L.P., ARCH Venture Fund IX Overage, L.P., BYBEE CLINTON, CRANDELL KEITH
Other (J): 75,000 @ $0 · Other (J): 75,000 @ $0 · Other (J): 958 @ $0 · Other (J): 306 @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-11-13 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1723172 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs